Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01246882 · ClinicalTrials.gov registry record · Phase 3

Stroke Inpatient Rehabilitation Reinforcement of ACTivity

A Phase 3 study, sponsored by University of California, Los Angeles.

Completed
Registry status
Phase 3
Development phase
140
Enrollment target

NCT01246882 is a Phase 3 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 140 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01246882, a Phase 3 study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Phase 3
Development phase
140 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effects of daily feedback about physical activity (number of bouts of walking, duration of bouts, total walking distance, average and fastest walking speed) and walking average speed compared to feedback about walking speed only on walking-related outcomes during inpatient rehabilitation for stroke. For the first time, daily walking and other exercise will be monitored by bilateral triaxial accelerometers on the ankles. Activity-recognition algorithms will analyze the inpatient sensor data and return a summary to the participants at each site.

Interventions

  • BEHAVIORAL Augmented activity feedback
  • BEHAVIORAL Speed-only feedback

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2011-01
Est. Completion 2012-11
Phase Phase 3

What the Registry Record Tells You About NCT01246882

The ClinicalTrials.gov registry entry for NCT01246882 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Augmented activity feedback is the first listed.

NCT01246882 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01246882 about?

NCT01246882 is a clinical study titled "Stroke Inpatient Rehabilitation Reinforcement of ACTivity". The purpose of this study is to determine the effects of daily feedback about physical activity (number of bouts of walking, duration of bouts, total walking distance, average and fastest walking speed) and walking average speed compared to feedback about walking speed only on walking-related outcom...

What is the current status of trial NCT01246882?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 140 participants. The study started on 2011-01. Estimated completion is 2012-11.

What interventions are being tested in trial NCT01246882?

The interventions under investigation include: Augmented activity feedback (BEHAVIORAL), Speed-only feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT01246882?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.